DWTX

Dogwood Therapeutics, Inc. - Common Stock (DWTX)

About Dogwood Therapeutics, Inc. - Common Stock (DWTX)

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Details

Daily high

$3.17

Daily low

$2.95

Price at open

$3.04

52 Week High

$9.50

52 Week Low

$2.60

Market cap

101.9M

Dividend yield

0.00%

Volume

49,805

Avg. volume

37,684

P/E ratio

-.12

Dogwood Therapeutics, Inc. - Common Stock News